Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.00055 | 1 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.00034 | 1 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.00023 | 1 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.00016 | 1 |